Compugen retains Porter Novelli Life
Compugen Ltd. today announced that it has retained Porter Novelli Life Sciences to design and execute an investor and public relations campaign to achieve greater recognition of Compugen's accelerating commercial progress and broadly applicable drug and diagnostic discovery capabilities in the US financial and media communities.
C&F Porter Novelli has unveiled a new brand identity and way of doing business, including a new logo and color scheme.